Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 6 | 2022 | 220 | 0.880 |
Why?
|
| Infant, Premature | 7 | 2022 | 851 | 0.580 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2006 | 168 | 0.460 |
Why?
|
| Blood-Brain Barrier | 4 | 2019 | 154 | 0.460 |
Why?
|
| Fetal Blood | 2 | 2014 | 176 | 0.430 |
Why?
|
| Neonatal Screening | 3 | 2011 | 201 | 0.370 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2015 | 253 | 0.370 |
Why?
|
| Sepsis | 2 | 2011 | 494 | 0.350 |
Why?
|
| Streptococcus agalactiae | 1 | 2011 | 102 | 0.340 |
Why?
|
| Infant, Newborn | 19 | 2022 | 8525 | 0.300 |
Why?
|
| Streptococcal Infections | 1 | 2011 | 251 | 0.290 |
Why?
|
| Cocaine | 3 | 1995 | 209 | 0.290 |
Why?
|
| Pregnancy Complications | 3 | 2019 | 535 | 0.260 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 499 | 0.260 |
Why?
|
| Emollients | 1 | 2006 | 2 | 0.240 |
Why?
|
| Spinal Puncture | 2 | 1996 | 52 | 0.240 |
Why?
|
| Pregnancy | 16 | 2022 | 7422 | 0.230 |
Why?
|
| Water-Electrolyte Balance | 1 | 2006 | 81 | 0.230 |
Why?
|
| Influenza, Human | 2 | 2023 | 700 | 0.230 |
Why?
|
| Syphilis, Congenital | 2 | 1996 | 32 | 0.230 |
Why?
|
| Pericardiocentesis | 1 | 2004 | 17 | 0.210 |
Why?
|
| Infant Mortality | 2 | 1995 | 184 | 0.210 |
Why?
|
| Trophoblasts | 2 | 2015 | 115 | 0.200 |
Why?
|
| Endothelial Cells | 2 | 2019 | 520 | 0.190 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 142 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1995 | 225 | 0.190 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2023 | 191 | 0.170 |
Why?
|
| Case-Control Studies | 5 | 2023 | 3387 | 0.170 |
Why?
|
| Thyroxine | 1 | 2000 | 59 | 0.160 |
Why?
|
| Erythrocyte Transfusion | 1 | 2001 | 141 | 0.160 |
Why?
|
| Substance-Related Disorders | 2 | 1995 | 480 | 0.160 |
Why?
|
| Fetal Growth Retardation | 3 | 2022 | 253 | 0.150 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2022 | 212 | 0.150 |
Why?
|
| Diabetes, Gestational | 2 | 2017 | 113 | 0.140 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 116 | 0.140 |
Why?
|
| Pregnancy Trimester, First | 2 | 2015 | 118 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 1996 | 78 | 0.130 |
Why?
|
| Database Management Systems | 1 | 2017 | 26 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 2 | 1995 | 169 | 0.130 |
Why?
|
| Infant, Premature, Diseases | 3 | 2011 | 254 | 0.130 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 66 | 0.120 |
Why?
|
| Gestational Age | 4 | 2022 | 1223 | 0.120 |
Why?
|
| Calpain | 1 | 2016 | 43 | 0.120 |
Why?
|
| Humans | 31 | 2023 | 130357 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2015 | 489 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 77 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2015 | 253 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 83 | 0.120 |
Why?
|
| Melatonin | 1 | 2016 | 30 | 0.120 |
Why?
|
| Meningitis | 1 | 1996 | 98 | 0.120 |
Why?
|
| Syphilis Serodiagnosis | 1 | 1995 | 15 | 0.120 |
Why?
|
| Chemokines | 1 | 2016 | 124 | 0.120 |
Why?
|
| Protease Inhibitors | 1 | 2016 | 95 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 134 | 0.120 |
Why?
|
| Quinazolines | 1 | 2016 | 177 | 0.110 |
Why?
|
| Hormones | 1 | 2016 | 163 | 0.110 |
Why?
|
| Postnatal Care | 1 | 1995 | 49 | 0.110 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2015 | 17 | 0.110 |
Why?
|
| Renin | 1 | 2015 | 75 | 0.110 |
Why?
|
| Female | 20 | 2022 | 70272 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 163 | 0.110 |
Why?
|
| Herpes Simplex | 1 | 2015 | 57 | 0.110 |
Why?
|
| Cyclic GMP | 1 | 2015 | 90 | 0.110 |
Why?
|
| Syphilis | 1 | 1995 | 95 | 0.110 |
Why?
|
| Incidence | 3 | 2022 | 3329 | 0.110 |
Why?
|
| Metabolomics | 1 | 2019 | 503 | 0.110 |
Why?
|
| Receptors, Artificial | 1 | 2014 | 1 | 0.110 |
Why?
|
| Thiourea | 1 | 2014 | 10 | 0.110 |
Why?
|
| Proteomics | 1 | 2019 | 609 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2016 | 346 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 126 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2014 | 73 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 471 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 568 | 0.100 |
Why?
|
| Retrospective Studies | 7 | 2022 | 17633 | 0.100 |
Why?
|
| Rats | 5 | 2019 | 3400 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1995 | 177 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2016 | 452 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2015 | 655 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 420 | 0.100 |
Why?
|
| Tobacco Use Disorder | 1 | 1993 | 89 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2015 | 233 | 0.100 |
Why?
|
| Glucose | 2 | 2015 | 853 | 0.100 |
Why?
|
| Delivery, Obstetric | 1 | 1995 | 255 | 0.090 |
Why?
|
| Birth Weight | 3 | 2022 | 341 | 0.090 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 321 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 233 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2011 | 64 | 0.090 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2022 | 341 | 0.090 |
Why?
|
| Craniosynostoses | 1 | 1993 | 156 | 0.090 |
Why?
|
| Urine | 1 | 1991 | 90 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 510 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2905 | 0.080 |
Why?
|
| Specimen Handling | 1 | 1991 | 145 | 0.080 |
Why?
|
| Seasons | 2 | 2023 | 333 | 0.080 |
Why?
|
| Adult | 8 | 2022 | 31093 | 0.080 |
Why?
|
| Risk Factors | 4 | 2022 | 10934 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 1474 | 0.070 |
Why?
|
| Male | 10 | 2022 | 64493 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 2923 | 0.070 |
Why?
|
| Young Adult | 3 | 2015 | 9970 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2111 | 0.060 |
Why?
|
| Vaccination | 2 | 2023 | 1040 | 0.060 |
Why?
|
| Hospitalization | 1 | 1995 | 1927 | 0.060 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 157 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2006 | 130 | 0.060 |
Why?
|
| District of Columbia | 2 | 1995 | 16 | 0.060 |
Why?
|
| Intestinal Atresia | 1 | 2005 | 21 | 0.060 |
Why?
|
| Hirschsprung Disease | 1 | 2005 | 37 | 0.060 |
Why?
|
| Bilirubin | 1 | 2006 | 126 | 0.060 |
Why?
|
| Ileum | 1 | 2005 | 108 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2014 | 6417 | 0.050 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2004 | 12 | 0.050 |
Why?
|
| Silicones | 1 | 2004 | 30 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1613 | 0.050 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2004 | 114 | 0.050 |
Why?
|
| Pericardial Effusion | 1 | 2004 | 72 | 0.050 |
Why?
|
| Infant | 4 | 2023 | 13277 | 0.050 |
Why?
|
| Prenatal Care | 2 | 1995 | 339 | 0.050 |
Why?
|
| Influenza B virus | 1 | 2023 | 102 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 620 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 128 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2023 | 149 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2942 | 0.040 |
Why?
|
| Deficiency Diseases | 1 | 2000 | 9 | 0.040 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 39 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 2000 | 28 | 0.040 |
Why?
|
| Cell Line | 2 | 2015 | 2577 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2022 | 426 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 39 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 266 | 0.040 |
Why?
|
| Permeability | 1 | 2019 | 119 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2021 | 396 | 0.040 |
Why?
|
| Animals | 5 | 2019 | 33909 | 0.030 |
Why?
|
| Logistic Models | 1 | 2022 | 1800 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 229 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 193 | 0.030 |
Why?
|
| Diastole | 1 | 2017 | 178 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 4700 | 0.030 |
Why?
|
| Aminophylline | 1 | 1996 | 7 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 837 | 0.030 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1996 | 24 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 167 | 0.030 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1996 | 74 | 0.030 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2015 | 7 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1996 | 249 | 0.030 |
Why?
|
| Guanylate Cyclase | 1 | 2015 | 33 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2016 | 191 | 0.030 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1995 | 22 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 1995 | 56 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1996 | 139 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 382 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 5190 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 1996 | 154 | 0.030 |
Why?
|
| Hypothermia | 1 | 1995 | 61 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 81 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 666 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 3030 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2014 | 51 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 83 | 0.030 |
Why?
|
| Patient Admission | 1 | 1995 | 184 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 51 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2014 | 39 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 93 | 0.030 |
Why?
|
| Imidazoles | 1 | 2015 | 219 | 0.030 |
Why?
|
| Brain Edema | 1 | 2014 | 66 | 0.030 |
Why?
|
| Adolescent | 3 | 2021 | 20724 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 259 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2016 | 405 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5073 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1300 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 325 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1995 | 1215 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 833 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2015 | 4671 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 333 | 0.020 |
Why?
|
| Research Design | 1 | 1996 | 716 | 0.020 |
Why?
|
| Premature Birth | 1 | 2016 | 421 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 767 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 372 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1607 | 0.020 |
Why?
|
| Infant Care | 1 | 1991 | 46 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2015 | 457 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1113 | 0.020 |
Why?
|
| Placenta | 1 | 2015 | 514 | 0.020 |
Why?
|
| Fetus | 1 | 1993 | 582 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1996 | 2298 | 0.020 |
Why?
|
| Reference Values | 1 | 1991 | 679 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6760 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 18203 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3799 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1283 | 0.020 |
Why?
|
| Prevalence | 1 | 1995 | 2682 | 0.020 |
Why?
|
| Child | 2 | 2023 | 26152 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 14976 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11813 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2000 | 12854 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 2377 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4660 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 20854 | 0.010 |
Why?
|
| Theophylline | 1 | 1996 | 23 | 0.010 |
Why?
|
| Apnea | 1 | 1996 | 26 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28338 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1996 | 974 | 0.010 |
Why?
|